SUPN
Supernus Pharmaceuticals Inc
NASDAQ: SUPN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$48.55
-0.29% today
Updated 2026-04-29
Market cap
$2.80B
P/E ratio
—
P/S ratio
3.89x
EPS (TTM)
$-0.68
Dividend yield
—
52W range
$29 – $60
Volume
0.7M
Supernus Pharmaceuticals Inc (SUPN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.23M | $8.89M | $37.92M | $106000.00 | $803000.00 | $1.48M | $12.02M | $122.05M | $144.43M | $215.00M | $302.24M | $408.90M | $392.75M | $520.40M | $579.77M | $667.24M | $607.52M | $661.82M | $718.95M |
| Revenue growth (YoY) | — | +110.0% | +326.7% | -99.7% | +657.5% | +84.3% | +712.1% | +915.4% | +18.3% | +48.9% | +40.6% | +35.3% | -3.9% | +32.5% | +11.4% | +15.1% | -8.9% | +8.9% | +8.6% |
| Cost of revenue | — | $336.00 | $-8.59M | $-13.40M | $37.68M | $42.78M | $1.10M | $5.76M | $8.42M | $11.99M | $15.21M | $15.36M | $16.66M | $52.46M | $75.06M | $87.22M | $83.78M | $77.91M | $74.56M |
| Gross profit | $4.23M | $8.89M | $46.51M | $13.51M | $803000.00 | $1.48M | $10.91M | $116.29M | $136.00M | $203.02M | $287.02M | $393.54M | $376.10M | $467.94M | $504.71M | $580.02M | $523.74M | $583.91M | $644.39M |
| Gross margin | 100.0% | 100.0% | 122.6% | 12745.3% | 100.0% | 100.0% | 90.8% | 95.3% | 94.2% | 94.4% | 95.0% | 96.2% | 95.8% | 89.9% | 87.1% | 86.9% | 86.2% | 88.2% | 89.6% |
| R&D | $19.27M | $30.46M | $29.26M | $35.15M | $30.63M | $23.52M | $17.25M | $19.59M | $29.14M | $42.79M | $49.58M | $89.21M | $69.10M | $75.96M | $90.47M | $74.55M | $91.59M | $108.80M | $106.23M |
| SG&A | — | $4.29M | $4.65M | $5.08M | — | $14.33M | $40.99M | $57.67M | $69.90M | $84.11M | $104.11M | $116.59M | $117.63M | $65.92M | $105.05M | $109.43M | $236.66M | $247.28M | $485.56M |
| Operating income | $-19.05M | $-25.86M | $4.02M | $-40.12M | $-37.75M | $-42.17M | $-61.92M | $24.23M | $17.66M | $54.22M | $99.54M | $144.44M | $148.57M | $173.70M | $86.03M | $46.12M | $-5.27M | $81.67M | $-36.86M |
| Operating margin | -449.9% | -290.9% | 10.6% | -37851.9% | -4701.4% | -2849.3% | -515.2% | 19.9% | 12.2% | 25.2% | 32.9% | 35.3% | 37.8% | 33.4% | 14.8% | 6.9% | -0.9% | 12.3% | -5.1% |
| EBITDA | $-16.34M | $-23.69M | $5.21M | $-38.29M | $-36.73M | $-41.84M | $-83.68M | $-4.35M | $21.77M | $56.62M | $107.67M | $151.51M | $180.42M | $210.54M | $129.19M | $153.36M | $90.04M | $178.28M | $41.00M |
| EBITDA margin | -386.0% | -266.5% | 13.7% | -36118.9% | -4573.5% | -2826.9% | -696.2% | -3.6% | 15.1% | 26.3% | 35.6% | 37.1% | 45.9% | 40.5% | 22.3% | 23.0% | 14.8% | 26.9% | 5.7% |
| EBIT | $-17.27M | $-24.80M | $4.14M | $-39.47M | $-37.60M | $-42.71M | $-84.42M | $-5.28M | $20.84M | $54.22M | $99.54M | $144.44M | $170.19M | $192.40M | $96.60M | $67.81M | $5.18M | $97.87M | $-49.03M |
| Interest expense | $1.77M | $8.68M | $122000.00 | $107000.00 | $1.87M | $3.58M | $7.85M | $5.62M | $4.77M | $5.09M | $1.57M | $18.11M | $22.71M | $23.75M | $23.42M | $7.07M | $2.42M | $0.00 | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-17.27M | $-33.48M | $460000.00 | $-38.46M | $56.00M | $-46.28M | $-92.27M | $19.87M | $14.02M | $91.22M | $57.28M | $110.99M | $113.06M | $126.95M | $53.42M | $60.71M | $1.32M | $73.86M | $-38.55M |
| Net income growth (YoY) | — | -93.8% | +101.4% | -8461.5% | +245.6% | -182.6% | -99.4% | +121.5% | -29.5% | +550.8% | -37.2% | +93.8% | +1.9% | +12.3% | -57.9% | +13.6% | -97.8% | +5512.8% | -152.2% |
| Profit margin | -408.0% | -376.7% | 1.2% | -36285.8% | 6974.2% | -3127.3% | -767.7% | 16.3% | 9.7% | 42.4% | 19.0% | 27.1% | 28.8% | 24.4% | 9.2% | 9.1% | 0.2% | 11.2% | -5.4% |